NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2016 to Q4 2025

Type / Class
Equity / Common Stock, Par Value $0.01 per share
Symbol
NVAX on Nasdaq
Shares outstanding
162,190,120
Price per share
$6.72
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
103,177,862
Total reported value
$894,342,655
% of total 13F portfolios
0%
Share change
+1,271,179
Value change
+$22,912,387
Number of holders
241
Price from insider filings
$6.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SHAH CAPITAL MANAGEMENT 8.3% +14% $116,713,633 +$14,305,500 13,461,780 +14% Himanshu H. Shah 10 Nov 2025
BlackRock, Inc. 8.4% $78,819,408 13,450,411 BlackRock, Inc. 31 Dec 2024

As of 30 Sep 2025, 241 institutional investors reported holding 103,177,862 shares of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX). This represents 64% of the company’s total 162,190,120 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.4% 15,194,563 -1.5% 0% $131,736,862
BlackRock, Inc. 7.9% 12,773,053 +0.23% 0% $110,742,371
SHAH CAPITAL MANAGEMENT 7.3% 11,811,780 +2.6% 18% $102,408,133
STATE STREET CORP 4.4% 7,196,719 +5.5% 0% $62,395,554
Sanofi 4.2% 6,880,481 0% 23% $59,653,770
D. E. Shaw & Co., Inc. 2.6% 4,274,079 +8.5% 0.03% $37,056,265
COATUE MANAGEMENT LLC 2.4% 3,836,986 0% 0.08% $33,266,669
GEODE CAPITAL MANAGEMENT, LLC 2.3% 3,792,064 +0.63% 0% $32,882,382
UBS Group AG 2.2% 3,516,203 +56% 0.01% $30,485,480
BANK OF AMERICA CORP /DE/ 1.9% 3,101,074 -1.1% 0% $26,886,311
MILLENNIUM MANAGEMENT LLC 1.3% 2,127,279 +5.2% 0.01% $18,443,509
NORTHERN TRUST CORP 0.94% 1,529,117 +15% 0% $13,257,445
Allianz Asset Management GmbH 0.87% 1,409,734 +163% 0.02% $12,222,394
TSP Capital Management Group, LLC 0.86% 1,399,065 3.2% $12,129,894
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 1,331,286 +1% 0% $11,542,250
CITADEL ADVISORS LLC 0.79% 1,285,872 +55% 0.01% $11,148,510
HRT FINANCIAL LP 0.77% 1,245,708 +102% 0.04% $10,800,000
RENAISSANCE TECHNOLOGIES LLC 0.74% 1,196,750 +79% 0.01% $10,375,823
ROYAL BANK OF CANADA 0.71% 1,144,118 +6.2% 0% $9,918,000
MORGAN STANLEY 0.66% 1,076,444 -13% 0% $9,332,786
SG Americas Securities, LLC 0.57% 918,683 +1.8% 0.03% $7,965,000
GOLDMAN SACHS GROUP INC 0.49% 789,276 -2.2% 0% $6,843,023
FARALLON CAPITAL MANAGEMENT LLC 0.48% 780,000 +4775% 0.04% $6,762,600
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.45% 729,956 -22% 0.01% $6,328,718
TWO SIGMA INVESTMENTS, LP 0.43% 702,000 +30% 0.01% $6,086,340

Institutional Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,012,988 $6,806,951 +$500,785 $6.72 9
2025 Q3 103,177,862 $894,342,655 +$22,912,387 $8.67 241
2025 Q2 101,927,016 $642,597,235 +$26,723,539 $6.30 246
2025 Q1 98,479,389 $631,338,864 -$31,743,566 $6.41 238
2024 Q4 102,576,523 $824,769,966 -$12,859,809 $8.04 225
2024 Q3 93,728,334 $1,185,512,085 +$128,202,136 $12.63 234
2024 Q2 83,466,534 $1,059,940,551 +$101,331,614 $12.66 227
2024 Q1 75,471,688 $360,750,876 +$22,242,333 $4.78 198
2023 Q4 45,076 $216,365 -$2,176,105 $4.80 2
2023 Q3 61,183,136 $442,951,657 +$35,446,977 $7.24 213
2023 Q2 56,078,024 $416,589,562 -$21,696,828 $7.43 197
2023 Q1 60,010,055 $415,895,461 +$24,318,080 $6.93 205
2022 Q4 52,476,510 $539,187,986 +$138,743,110 $10.28 228
2022 Q3 35,009,889 $637,183,224 -$33,910,461 $18.20 206
2022 Q2 33,736,441 $1,729,940,031 -$29,616,370 $51.43 280
2022 Q1 33,000,316 $2,430,083,849 -$60,808,391 $73.65 338
2021 Q4 33,054,916 $4,731,855,645 -$715,010,249 $143.07 389
2021 Q3 37,231,269 $7,711,376,901 -$499,369,553 $207.31 415
2021 Q2 39,622,241 $8,406,144,378 -$534,637,538 $212.31 390
2021 Q1 42,357,483 $7,679,960,887 +$840,747,597 $181.31 367
2020 Q4 38,659,716 $4,311,927,948 +$718,108,064 $111.51 323
2020 Q3 32,239,891 $3,485,681,526 +$55,316,946 $108.35 295
2020 Q2 28,742,331 $2,390,175,404 +$1,452,591,056 $83.35 203
2020 Q1 10,586,738 $141,916,296 +$76,509,934 $13.58 101
2019 Q4 4,773,940 $18,499,820 -$2,562,571 $3.98 61
2019 Q3 6,713,570 $33,708,109 -$277,958 $5.02 64
2019 Q2 6,707,666 $39,311,069 +$30,246,949 $5.86 67
2019 Q1 4,356,661 $2,400,000 +$2,400,184 $0.55 3
2016 Q4 0 $0 -$2,080 $6.72 0
2016 Q3 1,000 $2,080 $0 $2.08 1
2016 Q2 1,000 $7,270 +$7,270 $7.27 1